A Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers
Clinical trial NCT04699669 · COMPLETED
Trial details
- NCT number
- NCT04699669
- Sponsor
- Caliway Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-27
- Primary completion
- 2019-08-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.